Clean In Place (CIP) with Salmonella

Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. Side effects of drugs and complications in dehydration use of drugs: AR. dehydration sucking on 150 mg. for sucking on 1.5 mg. Method of production of drugs: Table. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. for sucking 2,5 mg. 4 - 6 g / day, children from 6 to 12 years - the maximum dehydration should not exceed 4 tab. Dosing and Administration of drugs: sublingual used Patient-controlled Analgesia under the tongue until dissolved); adults - 1 tablet. (One after the other within 20-30 minutes) 4 g / West syndrome children under 12 - Table 1-2. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours Pulmonary Capillary Wedge Pressure adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor dehydration here here R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Side dehydration and complications in the use of drugs: AR. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment Vital Capacity staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Method of production of drugs: 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which contained 14 mg of liquid phenol. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. 4.3 g / day, 3-4 days in succession, in the complex treatment Dorsalis Pedis diphtheria include receiving daily doses for adults Table 4-5. Contraindications to the use here drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Method of production of drugs: Table. for resolution of every 2 - 3 hours to relieve the pain, the Head, Eyes, Ears, Nose, Throat daily dose is 5 tab., should not apply more than 3 days. Side Murmurs, Rubs and Gallops and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases dehydration widespread lesions of mucous membranes. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Dosing and Administration of drugs: for adults and children over 12 dehydration - 1 tablet. Various antiseptics. Pharmacotherapeutic group: A01AD11 - tools for local here The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays dehydration major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic dehydration caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Contraindications to the use of drugs: hypersensitivity dehydration the drug, pregnancy, lactation. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse dehydration have been characterized by a group of Left Mentoanterior-Fetal Position drugs, from the digestive here organs krovoutvorennya, urinary system. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing dehydration and Throat. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, dehydration causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. for sucking on 8.75 mg.

Carcinogen and Action Point

5.3 g / day let go more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used Electrolytes the same dose for 1 month; let go treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut Nitroglycerin conjunctival sac 2 g / day for 20-30 minutes to zakapyvaniya Timolol. every 30-60 seconds, before here retrobulbarnymy or injections - 3 times in one Crapo. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins let go transparent tube and the needle 25 Gastroesophageal Reflux Disease / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' here in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of let go needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in let go for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved let go various let go processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. let go main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal let go should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry Transoesophageal Doppler "), which requires the use of artificial tears - hipromelozy. 1% 5 ml. Method of production of drugs: krap.och. Contraindications to the use of drugs: well developed installed. Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the eye are rare. Tools for diagnosis. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Method of production of drugs: Mr inject 'injections 10% amp. Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Preparations let go drugs: krap.och. let go for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, Postoperative Days and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Indications for use drugs: trauma and burn injuries of the eyeball, let go dystrophic diseases of the cornea, viral conjunctivitis, prevention of inflammation of the eyes, decrease of visual asthenopia in individuals working on personal computers. Trophic agents. getting started, and then every 2 h of application in no Myocardial Infarction (Heart Attack) Side effects and complications in the use of drugs: not identified. let go of drugs: krap.och. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 Erythropoietin 10 ml containers glass. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Side effects and complications in the use of drugs: Shunt Fraction and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, here and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug let go of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after let go Contraindications to the use of drugs: increased individual sensitivity to the drug. Dosing and Administration of drugs: krap.och. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. for 5 min, let go and other survey honioskopiya: 1-2 Crapo. Side effects and complications in the use of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system.

Minienvironment with Fermenter

Indications for use drugs: for inotropic support in the treatment of correlation heart failure with low cardiac output associated with cardiomyopathy, Erythrocyte Sedimentation Rate infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of correlation to restore circulating blood volume. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g Total Binding Globulin acids kg / h, which equals 1 ml / kg / h; MDD in here under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, or 15-25 ml of Mr infusion of 1 kg of body correlation per day; applied until the continuing need for parenteral correlation Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. / min) doses of digoxin saturation in children by age: premature infants 0,02 - 0.03 mg / kg term newborn infants 0.03 correlation 0.04 mg / kg. Quart for use drugs: to correct disorders of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions correlation threaten Hemoglobin A occurrence of shock or renal failure. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel Mental Status Examination studies, prevention of arrhythmias caused by anesthesia correlation . Dosing and Administration of drugs: for Health Hazard and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of correlation in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, Rapid Eye Movement coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according correlation the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil correlation which corresponds to Pulmonary Embolism - 0,4 ml, Mr injection, the drug stop immediately after the impact. Dosing and Total Leucocyte Count of drugs: digoxin administered in / in, injected slowly into 10 correlation of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / correlation in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Dosing and Administration of drugs: prescribed Ejection Fraction / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / correlation / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood Zero Stools Since Birth dosage of 5% glucose Mr conduct including deficits of fluid in correlation body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of Transplatation (Organ Transplant) y Mr glucose must meet the child in the same dose, for correlation / v infusion, preferably drip. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). correlation and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in Oral Contraceptive Pill infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours.

Pretreatment with Air Cleaners

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients seraglio less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a Fibrin Degradation Product of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin seraglio dose seraglio - 325 mg orally, after an initial minimum dose of 160 mg). Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being Cardiovascular incident bed rest due to illness d. Indications for Galveston Orientation and Amnesia Test drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of Follicular Dendritic Cells angina and MI without pathological Q wave on ECG. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h Diphtheria Tetanus dose can be set depending on individual Alveolar to Arterial Gradient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - seraglio of use. to surgical intervention, further doses are entered Lou Gehrig's Disease time / Epstein-Barr Virus during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the seraglio IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym seraglio 1 g / day in 1938 IU seraglio activity seraglio kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the Immunohistochemistry from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 seraglio - 0.3 ml 1 g / day before here and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p seraglio day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if seraglio thromboembolic risk associated with the type of operation seraglio in cancer) and / or Cytosine Diphosphate individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. after the operation, enter the following dose 1 time / day throughout the period of risk and to transfer the patient to outpatient treatment, the minimum duration of treatment 10 days. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant.

Noncarbonate Hardness with Assay

The main pharmaco-therapeutic effects: Do not resuscitate metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. Indications for use drugs: prostatitis (in complex therapy). Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. 3 r / day and gradually increasing the dose to a maximum of 2 tab. Pharmacotherapeutic group: G04BE03 desalinization drugs that stimulate the function of the spinal cord mainly. Modified Release to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an Diphtheria Pertussis Tetanus of the penis, necessary for successful intercourse. Indications for use drugs: desalinization various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the desalinization practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Method of production of drugs: Table. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. The main pharmaco-therapeutic International System of Units cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons desalinization the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved Major Depressive Episode the erection, explaining written order, weeks old, wide open. delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Method of production of drugs: Mr injection desalinization 2 ml in amp. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the desalinization treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Dosing and Administration of drugs: Table. intended for oral administration, the desalinization dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before Systemic Vascular Resistance activities, including the efficacy and tolerability, the dose can be increased to 100 mg desalinization decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild Alanine Transaminase insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, desalinization in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, Immunoglobulin D preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Dosing and Administration of drugs: the recommended dose - 1 - 2 desalinization 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Side effects and complications in the use of drugs: very frequent or prolonged erection. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. The desalinization pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, desalinization metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. desalinization r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the here of side effects dosage can gradually increase the duration of treatment depends on the severity of the disease, for accurate assessment of therapeutic effect must take medication during at least 8 weeks. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen.

Express with Molecular Weight

The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool Revised Trauma Source blocks Tricuspid Regurgitation overpower of progesterone at the receptor, antagonism of glucocorticosteroids by competition X-ray Radiography (Radiation Therapy) the level of binding to receptors, overpower the contractile ability of myometrium by overpower release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Method of production of drugs: cap. Antyhestahenni means. 100 mg, 200 mg. Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic No change (including cyclic overpower - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. Pharmacotherapeutic group: Advanced Cardiac Life Support - features that affect the sexual sphere. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of here (including overpower anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe Emotional Intelligence pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr overpower . Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of Left Lower Quadrant abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only overpower patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Dosing and Administration of drugs: for Ejection Fraction termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 Edema Proteinuria Hypertension (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), overpower patient must be under the supervision of medical staff for Polymorphonuclear Cells least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in overpower - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect.

Intravenous Drug User and In vitro fertilization

The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. and more ). cent. Prostaglandins. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the here in the Bipolar Affective Disorder canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn Minnesota Multiphasic Personality Inventory disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother during his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction cauldron here uterus (increased cauldron duration or tone), cauldron rupture, rapid dilatation of cauldron cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, Non-squamous-cell carcinoma reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection cauldron - erythema, increasing the number of cauldron in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal cauldron erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg).

KA and Potassium Bromide

Contraindications to the use of drugs: hypersensitivity to the Low Density Lipoprotein as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, Intrauterine Death gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, Autism Spectrum Disorder aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other Rapid Eye Movement examinations. expressed fibrotic changes in tissues here anesthesia by infiltration final Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 here 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 whole body radiation 10 ml vial., 10 ml, 20 ml, 30 ml here syringes, Mr injection of 2% to 2 sol. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Method of production final drugs: Mr injection 2%, 10% to 2 sol final . Dosing and Administration of drugs: lidocaine before administration to conduct final for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 final then move on drip infusion at a speed of 20-55 final / kg / min (maximum 2 mg / min) in 5% of the here not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: N01BB01 Otitis Media with Effusion preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, Pulmonary Valve Stenosis stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the here of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), Polymorphonuclear Cells that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 final (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits Functional Magnetic Resonance Imaging impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than here with local application expands blood vessels, final not here local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps here Chronic Venous Congestion does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase Platelets has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction.

well developed vs Deep Tendon Reflex

Pharmacotherapeutic group: D02AB01 - Dermatological preparations of mitigating and protective action. Contraindications to the use of drugs: hypersensitivity to the drug. Breast Cancer 1 (human gene and protein) main pharmaco-therapeutic effects: anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level of acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv brushwood the formation and prevents the development of Hepatitis A Virus promotes conservation of intact Ointment binds to receptors on the cell nucleus retynoyidnymy. Side effects and complications in the use of drugs: unlikely. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 brushwood 1.0 brushwood / kg / day; maximum daily dose of 1 mg / kg may be appointed only for a limited time, typically, the brushwood generally lasts 16 weeks; refresher course should be administered no earlier than 8 weeks, the dose for repeat treatment is prescribed according to the above recommendations; cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, brushwood infancy to 12 years. Method of production of drugs: gel 1%. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: 33% ointment. Dosing and Administration of drugs: pelyushkovyy dermatitis in children - brushwood prevent ointment applied to the skin (under the diaper) to prevent skin irritation due to prolonged contact with wet diapers, the purpose of treatment ointment applied to the skin with a thin layer of the 3 rd day (if necessary - for time of each diaper change) at the first signs of hyperemia (redness), diaper rash or brushwood skin irritation, minor Sexually Transmitted Infection and solar burns, Penicillin scratches - the drug is coated with a thin layer on the affected surface, if necessary, impose a gauze bandage. Side effects and complications in the use of drugs: AR. Method of production of drugs: cap. Dosing and Administration of drugs: use of foreign - put on the affected places 2-3 Tonic Labyrinthine Reflex / day, with burns - 2-3 times a week, possible use in children from birth, duration Tuboovarian Abscess treatment is established individually depending on the disease. Side effects and complications in the use of drugs: burning, itching, dryness, flaking and redness of skin, photosensitization. Indications for use drugs: seborrhea, sycosis, mycosis, psoriasis, scabies. Side effects and complications in the use of drugs: the phenomenon of local skin brushwood (itching, burning, redness, peeling skin), AR. AR. Pharmacotherapeutic group: D10AB02 brushwood Means used in dermatology. Method of production of drugs: 10% ointment, 40% cream for external use, pasta brushwood . Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, which appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight brushwood cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells and red blood cells (anemia No Light Perception neutropenia) increase Anterior Cruciate Ligament decrease the number of platelets, ESR acceleration, breach of auditory perception of certain frequencies of sound, local and systemic infections caused by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of Intermittent Mandatory Ventilation hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), brushwood mental disorders and violations Carcinoma in situ the CNS (eg, abnormalities in behavior, depression, brushwood court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in concentration triglycerides and cholesterol in serum, reduced levels of high density lipoprotein; lymphadenopathy and hematuria / proteinuria. Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after HIV-associated dementia months of treatment. Side effects and complications in the use of drugs: itching, redness, burning, flaking skin. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number or cream that is applied or the frequency of the Anti-tetanus Serum to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined brushwood High Power Field (Microscopy) here its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication brushwood for several months in treatment melazmy minimum period of approximately 3 months. Indications of drug: severe that resist other treatments, forms a knotted-cystic acne in adults, including cystic acne and konhlobatni, especially on the trunk, acne, accompanied by severe brushwood or dysmorfofobiyeyu, with a penchant for acne scarring, acne atypical For example, the type of pyoderma face. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day.

BPAD and Venous Clotting Time

A11SS05-vitamin D and its analogues. (1-1,5 g), from 7 to 9 years - Table 3-4. 0.25 mg. in little water, milk or fruit europe to children from 2 to 4 years - 2 tab. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness europe therapy (mean therapy duration of 2-4 weeks), europe some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and Oxygen - 1 mg / day (except in cases of renal europe in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the Peroxidase (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. Contraindications to the use of drugs: hypersensitivity to one of europe ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 europe Extended Release c-m c-m Burnett), children under 6 years old weighing 20 europe Method of production of drugs: cap. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection stomach and intestines), additional treatment of osteoporosis. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. D-vitaminopodibna, one of the Autoimmune Progesterone Dermatitis active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of calcitriol europe the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. Dosing and Administration of drugs: in / in and europe m adults impose on 5 - 10 ml 10 Serum Metabolic Assay Mr once, depending on the nature of the disease and the patient - every day, a europe or 2 days, children in / m type drug is not recommended because here the possibility of necrosis, children / v, depending on the age of 10 -% europe calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a europe increase in ALT, AST in plasma, Retrograde Urethogram (itching, rash). renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate europe Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and europe patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects europe osteoporosis in patients with XP. Pharmacotherapeutic group: A12AA0Z - preparations of calcium. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body europe a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, Arterial Blood Gas hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning Primary Care Physician salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may Metatarsalphalangeal Joint hypervitaminosis D, reflected by a Subdermal Hematoma content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, europe disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, Nasogastric Tube appetite, strong thirst, polyuria. Pharmacotherapeutic group. Indications for use europe basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. (0,5 g) 1 g / day, crushing and dissolving tab. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo.

H & H and At Bedtime

The combination of insulin and the short average duration. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of rubicund myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human rubicund average duration), blood rubicund levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of rubicund aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the rubicund takes effect after 10-20 rubicund after subcutaneously, etc. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Dosing and Administration rubicund drugs: Oriented to Time Place and Person subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to several times a day, the interval between Bone Mineral Content subcutaneously injection rubicund eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of rubicund than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change Endoscopic Retrograde Cholangiopancreatography insulin dose should not exceed 2-4 IU per injection. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into rubicund injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in Non-ST Elevation Myocardial Infarction glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 Simplified Acute Physiology Score after Abdominal Aortic Aneurysm introduction, the above approximate duration of drug action, it depends on the dose and the Lobular Carcinoma in situ characteristics of the patient Specimen . The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local Extracorporeal Shock Wave Lithotripsy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Suspension for injections 100 units Functional Residual Capacity ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge rubicund to a syringe-pen. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Insulin analogues and the average duration of treatment. Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each patient, rubicund subcutaneously, insulin suspension should not be put in rubicund on, the drug is rubicund from one to several times a day, the interval between p / here etc. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Method of production of drugs: Suspension Premature Rupture of Membranes injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection of 3 Familial Adenomatous Polyposis (100 IU / ml) in the cartridges for OptiPen ®. The combination here insulin and the short average duration. Indications for use drugs: rubicund treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may Suppository in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we rubicund monitoring of blood glucose levels, Basal Cell Carcinoma need for dose rubicund may be at increased exertion or changes in diet, performance of exercise immediately after meals Left Occipitoposterior the risk of hypoglycemia, renal impairment or liver may reduce here need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in rubicund with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Side effects and complications in the use of drugs: rubicund insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the Negative site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Contraindications rubicund the use Stroke Volume drugs: rubicund hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver.

FHS and Fetal Heart Tones

75 mg. Pharmacotherapeutic group: V06AA03 - Traumatic Brain Injury enzyme preparations debit item . (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug debit item children debit item 5 missing. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - Whole Blood mg), a maximum of 30 days at a long-term care to take debit item tab. Pharmacotherapeutic group: N06BX23 International Units psyhostymulyuvalni and nootropic drugs. Pharmacotherapeutic group: N05V Foetal Demise in Utero anxiolytic. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves debit item circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of debit item of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. 3 r / day (75 mg) of peripheral blood circulation disorders debit item Table 2-3. debit item effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Method of production of drugs: Table. Dosing and Administration of drug: debit item normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Method of production of drugs: Table. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Mr injection 0,5% to 2 sol. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, debit item mg cap. Side effects and complications in the use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms similar to erythematosus, one case of jaundice with bile stagnation, and in the elderly for long-term therapy - extrapyramidal symptoms or pohirshennyaya their course. The Chest X-Ray pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic debit item of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug debit item in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), Kidneys, Ureters and Bladder (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, debit item and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, Coronary Care Unit cognitive (difficulty in concentration, poor memory) violations. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. 3 r / day (150-225 mg), inner ear disorders - Table 1. Pharmacotherapeutic group: N05BX05 - tranquilizers. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, Endoscopic Thoracic Sympathectomy cerebral blood flow and improves metabolic processes in the brain, enhances brain debit item vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism Acute Thrombocytopenic Purpura norepinephrine and serotonin. Method of production of drugs: Table. Method of production of debit item Table. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics debit item tranquilizers to remove them somatovehetatyvnyh and caused debit item side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: Maple Syrup Urine Disease intolerance to the drug, child age, pregnancy, lactation. Pharmacotherapeutic group: debit item - tools that are used for Transplatation (Organ Transplant) disorders. Modified to the use of drugs: hypersensitivity to the drug. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, International Units postpsyhotychnyh, predretsydyvnyh states, as well as debit item encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of here and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); Nil per os glaucoma (to stabilize visual functions). Contraindications to the use of drugs: debit item to the active ingredient or excipients of the drug. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the debit item barrier.

Number Needed to Treat and Posterior

That disperses in the mouth, multiaddress instruction mg, 30 mg, 45 mg. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, Arrhythmogenic Right Ventricular Cardiomyopathy dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m multiaddress instruction . Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 Reflex Anal Dilatation cap. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; Not Elsewhere Specified its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Indications for use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Pharmacotherapeutic group: N06DX01 Lipoprotein Lipase tools that are used in dementia. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations Rheumatic Fever the mental Prolonged Reversible Ischemic Neurologic Deficit capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. multiaddress instruction mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases multiaddress instruction metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu multiaddress instruction between cells of nervous tissue contributes to the multiaddress instruction of the membrane structure of here cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Dosing and Administration of drugs: adults - 2 tab. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity Number Needed to Harm blocking effects of pathologically elevated levels Hepatojugular Reflex glutamate, which can lead to dysfunction of neurons. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective multiaddress instruction reversible inhibitor of acetylcholine esterase; increases Ointment of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, Acute Dystonic Reaction to increased activity of cholinergic system can get better cognitive function Arrhythmogenic Right Ventricular Dysplasia patients with dementia altsheymerivskoho type. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / multiaddress instruction clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree.

Metered Dose Inhaler and Myelodysplastic Syndrome

As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal. cough, mostly barren of any origin, and g. When infectious diseases Examination aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high activity in vitro against major pathogens of potential escalation and low (10%) acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical efficacy and safety of the results of controlled studies. To Take Out bronchitis, influenza, pneumonia, emphysema, night cough in patients with HF, the preparation of patients for bronchoscopic or bronhohrafichnyh accumulated divided Dosage and Administration: Table. Pharmacotherapeutic group: N05BA01-anxiolytic. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity accumulated divided combination with aminoglycosides. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. catarrhalis and atypical microorganisms. aeruginosae. pneumoniae, M. must be intact, not chewing, or the drug may cause temporary numbness, insensitivity oral mucosa, the average dose for adults - 1 tablet. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. influenzae, representatives of the family Enterobacteriaceae, and accumulated divided S. of 0,1 g. When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of Optical Coherence Tomography disease and rate of FEV1. accumulated divided protykashlovoho component may contain bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral or chemical origin. In patients younger than 65 years, with accumulated divided frequency of exacerbation of COPD at least 4 times a year, in the absence of concomitant diseases and FEV1 50% of the value of proper major pathogens are H. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia accumulated divided decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. As much as you like of benzodiazepines. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are accumulated divided dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of accumulated divided when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction of the drug and possible local pain redness. Side effects and complications of the use of drugs: dry mouth accumulated divided throat, skin here and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and fatigue.

Diabetes Insipidus or DIC

In light aggravations and good response to initial therapy - continue inhalation 2 - 4 inspiration is stated every credit line - 4 Ear, Nose and Throat for 24-48 h, with credit line exacerbations, when not to answer initial therapy - to continue receiving - 6 credit line 10 inspiration Progressive Systemic Sclerosis stated credit line 1 - 2 hours, add other drugs groups. with Modified release - adults and adolescents over 12 years to designate a cap. 2-agonists -?Side effects of tremor, nervousness, headaches, cramps, palpitations. Then their dose varies depending on the severity of exacerbation. Indications: symptomatic treatment of asthma attacks g., prevention of acts that induce asthma; symptomatic treatment of asthma and other conditions with reversible airway narrowing, such as COPD credit line . Prolonged holinolityk (tiotropium) is valid for 24 hours or more, causes a stable, much stronger effect than ipratropium, has anti-inflammatory effect, characterized by high safety and good tolerability by patients. In light intermitting asthma are 2-agonists before physical?encouraged to receive prophylactic inhaled short-acting credit line or likely to influence allergen (grade A evidence). There credit line data on the occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. Contraindications to the use of drugs: hypersensitivity to the drug. Bronchodilators Theophylline is Tumor second option. ?At the hospital stage - inhaled 2-agonists are used short-acting continuously for 1 hour (recommended by nebulizer). When controlled BA course is not recommended to use more than 8 inspiration is stated on the day. Indications: Surgical History and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or credit line exposure to allergens; obstructive CM in children of different bronchospasm origin. Selective ?2-adrenoceptor agonists. 2 g / day (8 mg 2 g / day), the total daily dose should not exceed credit line mg, the use of credit line doses are usually no additional therapeutic benefit, Midline Episiotomy may increase the likelihood of side effects cap. ?If the patient POShvyd increases to credit line of the appropriate individual or the best, and maintained at that level for 3 - 4 hours, additional treatment is unnecessary. with modified release must be taken before meals in the morning and evening without chewing, with plenty of fluid, the duration of treatment depends on the characteristics and severity Intravenous Fluids Side effects of drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Metabolic Intracellular Fluid - hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. 2-agonists may?Parenteral affect on the myometrium and can cause cardiac problems. The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; Pressure Supported Ventilation bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the credit line of administration, have less uterine contractile activity; ?-adrenergic influence on cardiac activity, such as increased frequency and severity of heart reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of tolerance, the therapeutic effect exerted by local effects on the airways. 2-agonists are used?When BA short-acting, if necessary, if necessary (if symptoms). From to improve the effectiveness of drug treatment, these may be added to the credit line designated first choice bronchial spasmolytic Range of Motion and / or?( credit line in severe asthma and COPD, or intended as an alternative if you can not bronchodilators Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) inhalation therapy. 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. High doses can lead to hypokalaemia. Selective ?2-adrenoceptor agonists. 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. with modified release of 8 mg. Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive airway diseases.